STAT

MARCH 21, 2024

are trying to figure out the nitty-gritty to replicate those early one-off successes for as many patients as possible — what sort of preclinical testing a tailor-made treatment needs to go through before being used, what regulatory thresholds each treatment needs to clear, and how to pay for these therapies.

102

102

STAT

JANUARY 18, 2024

And what’s going to move markets in 2024? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We also look ahead to the biggest biotech stories coming in 2024, including some major data readouts and a few pivotal FDA decisions. Read the rest…

FDA 101

FDA 101

STAT

MARCH 8, 2024

The latest disappointment in amyotrophic lateral sclerosis research brought crushing news for patients and physicians, forcing the community to consider just what to do with an approved medicine that doesn’t appear to work. Continue to STAT+ to read the full story…

FDA 140

FDA 140

STAT

MARCH 4, 2024

“We’re really pleased with the data. It’s exactly what we were hoping to see,” said Kitty Yale, Akero’s chief development officer, in an interview with STAT. ” Continue to STAT+ to read the full story…

119

119

STAT

FEBRUARY 8, 2024

  “We have received the first offer, but as you can imagine, we will not disclose what the offer is,” Ruud Dobber, the company’s executive vice president of biopharmaceuticals business, said at the event, held at the London Stock Exchange. Continue to STAT+ to read the full story…

103

103

STAT

DECEMBER 21, 2023

  But whether that wave of interest will persist into the new year, or transfer to some other condition — maybe some liver diseases that are troublingly on the rise — is what we’re asking our crystal ball.

109

109

IDStewardship

APRIL 16, 2023

This number was as high as 95% in 2013 so over the past decade we have seen close to a 20% drop in the pass rate. What are they and what can you do to prevent/overcome these potential pitfalls? We will discuss in this column and examen some reasons why people fail the NAPLEX. Why is this happening? Where are you weak?

Compounding 207

Compounding 207

IDStewardship

JUNE 1, 2023

BCPS, BCIDP Article Posted 3 June 2023 We have come a long way since the term “ Antimicrobial Stewardship ” first appeared in the medical literature in 1996, brought to us by John McGowan and Dale Gerding. Interview with: William Greendyke, M.D. Interview by: Timothy P. Gauthier, Pharm.D.,

Hospitals 131

Hospitals Nursing Homes Communication Medical Schools 131

IDStewardship

APRIL 30, 2023

The first section I composed having not read the responses on Twitter. As you read this, keep in mind I am not a financial expert, but here are a few things I picked up along the way. See if they do not mind sharing which plan they have and what they have learned from it. Composed By: Timothy P. Gauthier, Pharm.D.,

Health and Personal Care Stores 329

Health and Personal Care Stores Patient Care Insurance Hospitals 329

STAT

SEPTEMBER 14, 2023

What does Covid-19 have in store for the winter? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We also discuss the latest news in the life sciences, including an IPO implosion, a debate at the FDA, and the ups and downs of a career in biotech. Read the rest…

FDA 119

FDA 119

Board Vitals - Pharmacist

MARCH 13, 2024

What motivates you to wake up every morning? What are you looking for in a residency program? What was the feedback and how did you handle it? What questions do you have for me? What will you be able to bring to this program? What is the last book you read? Why should we not choose you?

105

105

STAT

OCTOBER 18, 2023

In reality, there are big variations in how much weight people lose on the therapies, and it’s unclear what explains those differences. “The variability is so wide that we want to understand what predicts response,” said Lee Kaplan, chief of obesity medicine at the Geisel School of Medicine at Dartmouth.

123

123

STAT

JANUARY 11, 2024

Morgan Healthcare Conference when we all collectively realized, “Oh, 2023 is going to be another slog.” “It’s not only what happened the last few weeks of the year, but what people are projecting moving forward.” ” Continue to STAT+ to read the full story…

120

120

STAT

NOVEMBER 16, 2023

In 1993, I published “Listening to Prozac,” a book that grew out of my clinical experience prescribing what was then a new class of medications, ones thought to moderate depression through their effect on the way that the brain handles the neurotransmitter serotonin. How open are we to technologies that might change it?

135

135

STAT

DECEMBER 26, 2023

“But we have other options for treating obesity. What we need to do now in research is understand which treatments, for which patients, at which stage of their disease. What we need to do now in research is understand which treatments, for which patients, at which stage of their disease.”

118

118

STAT

APRIL 10, 2024

We are doing just fine, thank you, especially since the middle of the week is upon us. After all, we have made it this far, so we are determined to hang on for another couple of days. The alternatives — at least those we can identify — are not so appetizing. Continue to STAT+ to read the full story…

87

87

STAT

SEPTEMBER 20, 2023

But as cases climb , those who’ve had the virus before may wonder: What are their chances of developing long Covid — and does the risk increase with each reinfection? We still can’t predict, prevent, or cure long Covid — or understand why it affects some people and not others. Read the rest…

145

145

STAT

FEBRUARY 28, 2024

We are doing just fine, thank you, especially since the middle of the week is upon us. After all, we have made it this far so we are determined to hang on for another couple of days. The alternatives — at least those we can identify — are not so appetizing. Continue to STAT+ to read the full story…

FDA 103

FDA Documentation Insurance 103

STAT

FEBRUARY 15, 2024

And what’s next in pain medicine? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Read the rest… Has PhRMA lost its fangs? Are 11th-hour changes ominous for clinical trials?

86

86

STAT

APRIL 11, 2024

We are doing just fine, thank you, despite the cloudy skies hovering over the unusually quiet Pharmalot campus. While the sun may not be shining, we will rely on sage advice from the Morning Mayor, who reminded us that every new day should be unwrapped like a precious gift. We appreciate your insights.

Chemotherapy 85

Chemotherapy Immunization 85

STAT

OCTOBER 2, 2023

There are times when a new medical technology is thrust into the public spotlight because it seems like it might solve what we thought was unsolvable. Read the rest… Not for the first time, this is being played out in the field of reproductive technology with in vitro gametogenesis, or IVG.

112

112

STAT

OCTOBER 26, 2023

What makes biotech stocks go up? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We also discuss the latest news in the life sciences, including the future of Alzheimer’s disease treatment, a multibillion-dollar deal, and the return of the biotech mega-round.

98

98

STAT

SEPTEMBER 1, 2023

But those doses were just a fraction of a percent of what the sprawling 35-hospital system needed to protect its 200,000 immunocompromised patients. Yes, we have a great therapy, but oh my gosh, how are we going to get this to all of our patients and make sure everyone has equitable access? Read the rest…

Hospitals 135

Hospitals 135

STAT

APRIL 8, 2024

We hope the weekend respite was relaxing and invigorating because the usual routine of online meetings, phone calls, and deadlines has inevitably returned. After all, what can you do? So in hopes of nudging it in a better direction, we are brewing cups of stimulation. We hope your day is meaningful and productive.

FDA 88

FDA 88

STAT

FEBRUARY 26, 2024

We hope the weekend respite was relaxing and invigorating, because — you know what we are going to say — that oh-so familiar routine of online meetings, endless calls and deadlines has returned. But what can you do? Our choice today is cinnamon vanilla, which we recently procured.

Insurance 95

Insurance 95

STAT

MARCH 30, 2023

What happened to the market for monkeys? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We explain how biotech is affected by a bizarre situation involving smuggled monkeys, international intrigue, and a criminal investigation. Read the rest…

78

78

STAT

SEPTEMBER 14, 2023

” “So what we want to do is make sure to fix it as quickly as we possibly can, but do it in a way that’s going to work,” Guthrie said. Continue to STAT+ to read the full story…

Hospitals 111

Hospitals 111

STAT

JANUARY 8, 2024

“We are not cash rich right now. We’re not in a position where we can do large acquisitions, and I believe we’re not in a position where we need to [in order] to grow the company in a meaningfully responsible way on an earnings basis for the longer term,” said Tim Wentworth, CEO of Walgreens Boots Alliance.

Insurance 102

Insurance 102

STAT

AUGUST 22, 2023

Transgender Americans are both living and dying among us: precisely why we health care providers must improve our approaches to ensuring dignified and respectful care for transgender elders, especially at the end of life. We all want to live our last days authentically. Read the rest…

95

95

STAT

NOVEMBER 3, 2023

The CF community’s baby-boom we’ve all worked toward has happened thanks to this drug. But access to Trikafta is now at risk for several hundred people with CF, because of what some might consider to be good intentions. Read the rest… Five years later, the worst parts of my CF are gone.

Hospitals 134

Hospitals 134

STAT

FEBRUARY 14, 2024

We are doing just fine, thank you, especially since the middle of the week is upon us. After all, we have made it this far so we are determined to hang on for another couple of days. The alternatives — at least those we can identify — are not so appetizing. Continue to STAT+ to read the full story…

92

92

STAT

SEPTEMBER 22, 2022

What are all the cell types in the brain? How do the workings of the brain change during disease, and what can we do about that? How do the workings of the brain change during disease, and what can we do about that? Read the rest… How are they connected to one another?

130

130

STAT

MAY 25, 2023

And what makes AI hallucinate? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We also discuss the latest twist for Sarepta Therapeutics and the quest to develop more potent weight loss medicines. Read the rest… Can AI diagnose a disease?

Hospitals 77

Hospitals FDA 77

STAT

SEPTEMBER 29, 2023

It is a bad omen, then, that while statisticians are known for pestering researchers with difficult but important questions like “ What are we even trying to learn? Read the rest… ”, Code Interpreter responds to even half-baked requests with a cheerful “Sure, I’d be happy to.”

111

111

STAT

AUGUST 17, 2023

What difference does a day make? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Read the rest… Who gets to have gene therapy? And are biotech startups OK?

92

92

The Checkup by Singlecare

DECEMBER 7, 2023

At SingleCare, we value and appreciate the dedication and service you provide to your customers and community. That’s why every October, in honor of American Pharmacist’s Month, we host the Best of the Best Pharmacy Awards to recognize pharmacy professionals who go above and beyond. Read more here. Read more here.

Controlled Substances 52

Controlled Substances Pharmaceutical Companies Pharmaceutical Companies FDA 52

STAT

OCTOBER 23, 2023

We hope the weekend respite was relaxing and invigorating because — you know what we will say — the predictable routine of online meetings and deadlines has returned. But what can you do? So to cope, we are quaffing cups of stimulation. We have returned to pistachio creme this morning.

81

81